Skip to content

AI Ethics in Pharma & Life Sciences: A Market-Oriented Approach? Dec 4th, 5-7pm

AI Ethics in Pharma & Life Sciences: A Market-Oriented Approach? Dec 4th, 5-7pm Article Image

5. November 2024

AI Ethics in Pharma & Life Sciences: A Market-Oriented Approach?

When: December 4th, 17:00-19:00

Where: Digital Society Initiative, Rämistrasse 69, Zurich

Organizers: DSI and MQ Learning Academy

Registration

Registration AI ethics

Name(Required)
Email
Please let us know what's on your mind. Have a question for us? Ask away.

Description

In today’s rapidly evolving digital landscape, AI and other emerging technologies are transforming industries, including healthcare and pharma, by offering innovative capabilities and enhanced efficiency. However, the rise of AI brings with it new ethical challenges beyond traditional concerns of security and data protection. 

In this session, we will explore the importance of AI ethics within the pharma and life sciences sectors, focusing on practical strategies to mitigate risks while ensuring AI-driven innovation. We’ll examine how a market-oriented approach can be combined with regulatory frameworks to address these concerns responsibly. Additionally, we’ll present key findings from an Innosuisse-funded study, conducted in collaboration with the University of Zurich and MQ Academy, on AI ethics in pharma and life sciences.

Agenda:

5:00 – 5:10 Welcome

5:10-5:40 Presentation of the Innocheque study results by Deepak Bansal, Michele Loi (via Zoom), and Christian H. Hoffmann, showcasing key findings on AI ethics in pharma and life sciences

5:40-5:50 Q&A

5:50-6:10 Presentation by Dr. Katraina Bremstedt from Roche, “Ethical AI at Roche”

6:10-6:20 Q&A

6:20-6:40 Presentations by Dr. Eleonora Viganò, offering additional perspectives on AI ethics and industry challenges

6:40-6:50 Q&A

6:50-7:15 Discussion

Why Attend?

This event is an excellent opportunity for professionals in the pharmaceutical industry, AI specialists, ethicists, and regulatory bodies to gain a deeper understanding of how AI ethics can be managed within the unique context of pharma. Whether you’re looking to enhance your company’s AI governance strategy or simply learn more about the ethical implications of AI in this sector, this event will offer valuable insights and practical takeaways.